Stockscreener 앱 받기
2.79
22.37%
0.51
시간 외 거래:
2.82
0.03
+1.08%
전일 마감가:
$2.28
열려 있는:
$2.38
하루 거래량:
576.51K
Relative Volume:
5.09
시가총액:
$10.60M
수익:
$881.00K
순이익/손실:
$-13.67M
주가수익비율:
-0.2557
EPS:
-10.9133
순현금흐름:
$-14.20M
1주 성능:
+22.91%
1개월 성능:
+1.82%
6개월 성능:
-53.67%
1년 성능:
-88.52%
1일 변동 폭
$2.38
$3.14
1주일 범위
$2.07
$3.14
52주 변동 폭
$2.07
$25.10
Seastar Medical Holding Corp Stock (ICU) Company Profile
명칭
Seastar Medical Holding Corp
전화
844-427-8100
주소
3513 BRIGHTON BLVD, DENVER
Compare ICU vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICU
Seastar Medical Holding Corp
|
2.79 | 8.66M | 881.00K | -13.67M | -14.20M | -10.91 |
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.73 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
692.83 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.60 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Seastar Medical Holding Corp 주식(ICU)의 최신 뉴스
SeaStar Medical Holding Corp (ICU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Gains Report: Can SeaStar Medical Holding Corporation Equity Warrant reach all time highs this year2026 Trade Ideas & AI Based Buy and Sell Signals - baoquankhu1.vn
SeaStar Medical Holding Corp reports results for the quarter ended September 30Earnings Summary - TradingView
Earnings call transcript: SeaStar Medical’s Q4 2025 revenue soars, stock edges up - Investing.com Australia
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
SeaStar Medical Holding 2025 10-K: Revenue $1.234M, EPS $(5.86) - TradingView
SeaStar Medical (NASDAQ: ICU) details QUELIMMUNE launch and pivotal AKI trial - Stock Titan
SEASTAR MEDICAL HOLDING ($ICU) Releases Q4 2025 Earnings - Quiver Quantitative
SeaStar Medical reports $1.2M revenue for 2025, narrows annual loss to $12.2M - TradingView
[8-K] SeaStar Medical Holding Corp Reports Ma... - Stock Titan
13 more children's hospitals adopt SeaStar therapy as AKI trial tops 50% - Stock Titan
SeaStar Medical Holding Corp expected to post a loss of $1.06 a shareEarnings Preview - TradingView
If You Invested $1,000 in SeaStar Medical Holding Corp (ICU) - Stock Titan
ICU Technical Analysis & Stock Price Forecast - Intellectia AI
Aug Catalysts: Can SeaStar Medical Holding Corporation continue delivering strong returnsSell Signal & Reliable Intraday Trade Alerts - baoquankhu1.vn
EV Market: Can SeaStar Medical Holding Corporation be the next market leaderQuarterly Growth Report & Fast Moving Trade Plans - baoquankhu1.vn
SeaStar Medical Highlights SCD Platform, QUELIMMUNE Growth and NEUTRALIZE-AKI Timeline at Forum - Defense World
Insider Buy: Will SeaStar Medical Holding Corporation stock recover after earnings2026 Top Decliners & Accurate Technical Buy Alerts - baoquankhu1.vn
SeaStar Medical (ICU) Expected to Announce Earnings on Thursday - Defense World
SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026 - ChartMill
After-hours results: SeaStar Medical sets March 25 webcast - Stock Titan
OTC Markets Hosts Virtual Investor Presentation with Eric Schlorff, CEO of SeaStar Medical, and David Bautz, PhD, Senior Analyst at Zacks SCR - Yahoo Finance
Trend Report: How does SeaStar Medical Holding Corporation compare to its peers2026 Buyback Activity & AI Forecast Swing Trade Picks - baoquankhu1.vn
ICU Stock Price, Quote & Chart | SEASTAR MEDICAL HOLDING CORP (NASDAQ:ICU) - ChartMill
Signal Recap: Does SeaStar Medical Holding Corporation offer margin of safetyTrend Reversal & Safe Entry Zone Tips - baoquankhu1.vn
B2i Digital Highlights Life Sciences Virtual Investor Forum as a Featured Conference - TradingView
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th - The Manila Times
SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th - The Manila Times
SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI - ChartMill
Short Interest in SeaStar Medical Holding Corporation (NASDAQ:ICU) Rises By 85.5% - Defense World
SeaStar Medical (NASDAQ:ICU) vs. Organon & Co. (NYSE:OGN) Financial Contrast - Defense World
Is SeaStar Medical Holding Corporation likely to announce a buybackQuarterly Trade Report & Stepwise Trade Signal Guides - mfd.ru
ICU Should I Buy - Intellectia AI
Aug Weekly: Will SeaStar Medical Holding Corporation stock recover after earningsTrade Volume Report & Growth-Oriented Investment Plans - baoquankhu1.vn
ICU Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
What are SeaStar Medical Holding Corporation’s earnings expectationsGap Up & AI Forecasted Entry/Exit Points - mfd.ru
SeaStar Medical Holding Co. (NASDAQ:ICUCW) Short Interest Down 12.5% in January - Defense World
How SeaStar Medical Holding Corporation Equity Warrant stock trades before earnings2025 Big Picture & Weekly Momentum Stock Picks - mfd.ru
Can SeaStar Medical Holding Corporation Equity Warrant stock reach $100 price target2025 Buyback Activity & Safe Investment Capital Preservation Plans - mfd.ru
Investors report 9.99% SeaStar Medical (ICU) ownership via warrants - Stock Titan
SeaStar Medical price target lowered to $6 from $10 at Maxim - TipRanks
ICU: Publication Validates Real-World Clinical Impact of QUELIMMUNE in Pediatric AKI - Smartkarma
ICU News Today | Why did SeaStar Medical stock go up today? $ICU - MarketBeat
Published on: 2026-02-11 10:56:42 - mfd.ru
Director Kenneth Van Heel awarded 3,000 RSUs at SeaStar Medical (ICU) - Stock Titan
SeaStar Medical reports strong survival data for QUELIMMUNE therapy By Investing.com - Investing.com Australia
SeaStar Medical stock falls after publishing pediatric therapy data By Investing.com - Investing.com Nigeria
SeaStar Medical stock falls after publishing pediatric therapy data - Investing.com Australia
SeaStar Medical reports ‘strong’ survival data in Quelimmune study - TipRanks
SeaStar Medical reports strong survival data for QUELIMMUNE therapy - Investing.com
SeaStar Medical Reports Positive 90-Day Survival Data for QUELIMMUNE Therapy in Pediatric Patients with Acute Kidney Injury - Quiver Quantitative
Seastar Medical Holding Corp (ICU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Seastar Medical Holding Corp 주식 (ICU) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Messinger Michael | Chief Financial Officer |
Dec 09 '25 |
Buy |
0.35 |
14,500 |
5,098 |
17,500 |
| Van Heel Kenneth | Director |
Aug 26 '25 |
Buy |
0.89 |
25,000 |
22,248 |
39,400 |
| Van Heel Kenneth | Director |
Aug 27 '25 |
Buy |
0.86 |
10,000 |
8,565 |
49,400 |
| Chung Kevin | Chief Medical Officer |
Aug 22 '25 |
Buy |
0.80 |
10,000 |
8,000 |
58,184 |
| Neuman John | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
88,000 |
| Vincent Bernadette N | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
8,000 |
| Van Heel Kenneth | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
4,000 |
0 |
10,400 |
| Chung Kevin | Chief Medical Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
5,000 |
0 |
48,184 |
| Schlorff Eric | Chief Executive Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
21,667 |
0 |
98,517 |
| Baird Jennifer A | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
18,000 |
0.04%
0.06%
자본화:
|
볼륨(24시간):